Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11

被引:102
作者
Li, T
Ball, D
Zhao, J
Murray, RM
Liu, X
Sham, PC
Collier, DA
机构
[1] Inst Psychiat, Dept Psychol Med, London SE5 8AF, England
[2] W China Univ Med Sci, Dept Psychiat, Sichuan 610041, Peoples R China
[3] Inst Psychiat, Ctr Social Genet & Dev Psychiat, London SE5 8AF, England
基金
英国惠康基金; 中国国家自然科学基金;
关键词
psychosis; allelic association; ARVCF; COMT; TDT; family trios; LD maps;
D O I
10.1038/sj.mp.4000638
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Family-based linkage disequilibrium mapping using SNP markers is expected to be a major route to the identification of susceptibility alleles for complex diseases. However there are a number of methodological issues yet to be resolved, including the handling of extended haplotype data and analysis of haplotype transmission in sib-pair or family trio samples. In the present study, we have analysed two dinucleotide repeat and six SNP markers at the COMT locus at chromosome 22q11, a region implicated in psychosis, for transmission distortion in 198 Chinese schizophrenic family trios. When individual markers were analysed using the TDT, two showed modest evidence of transmission distortion (186C/T, P = 0.04; Val168Met, P = 0.01). Using haplotypes of paired markers analysed by the program TRANSMIT, the most significant P value was 0.001, for the Met158Val and 900ins/delC polymorphisms in the COMT gene. The global P value for the haplotypes of ail six SNP markers tested was 0.004, largely a result of the excess transmission of two extended haplotypes which differed at the marker 408C/G. The exclusion of this marker from the analysis gave a global P value of 0.002 and produced a five marker haplotype system which was significant at P = 0.0006. This haplotype consisted of the alleles -287G:186C:Val158:900insC:ARVCF930C, which may represent a background haplotype for the transmission of a schizophrenia susceptibility allele at chromosome 22q11. Our results support the hypotheses that either COMT is itself a susceptibility gene, or more likely that this region of chromosome 22 contains a susceptibility gene that is in linkage disequilibrium with COMT alleles.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 56 条
  • [21] SCHIZOPHRENIA SUSCEPTIBILITY ASSOCIATED WITH INTERSTITIAL DELETIONS OF CHROMOSOME 22Q11
    KARAYIORGOU, P
    MORRIS, MA
    MORROW, B
    SHPRINTZEN, RJ
    GOLDBERG, R
    BORROW, J
    GOS, A
    NESTADT, G
    WOLYNIEC, PS
    LASSETER, VK
    EISEN, H
    CHILDS, B
    KAZAZIAN, HH
    KUCHERLAPATI, R
    ANTONARAKIS, SE
    PULVER, AE
    HOUSMAN, DE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) : 7612 - 7616
  • [22] A genome survey of bipolar disorder indicates a susceptibility locus on chromosome 22.
    Kelsoe, JR
    Loetscher, E
    Spence, MA
    Foguet, M
    Sadovnick, AD
    Remick, RA
    Flodman, P
    Masser, D
    Ungerleider, S
    Rapaport, MH
    Wishart, WL
    Luebbert, H
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 81 (06): : 461 - 462
  • [23] Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder
    Kirov, G
    Murphy, KC
    Arranz, MJ
    Jones, I
    McCandles, F
    Kunugi, H
    Murray, RM
    McGuffin, P
    Collier, DA
    Owen, MJ
    Craddock, N
    [J]. MOLECULAR PSYCHIATRY, 1998, 3 (04) : 342 - 345
  • [24] KLITZ W, 1995, AM J HUM GENET, V57, P1436
  • [25] Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families
    Kunugi, H
    Vallada, HP
    Sham, PC
    Hoda, F
    Arranz, MJ
    Li, T
    Nanko, S
    Murray, RM
    McGuffin, P
    Owen, M
    Gill, M
    Collier, DA
    [J]. PSYCHIATRIC GENETICS, 1997, 7 (03) : 97 - 101
  • [26] Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders
    Lachman, HM
    Papolos, DF
    Saito, T
    Yu, YM
    Szumlanski, CL
    Weinshilboum, RM
    [J]. PHARMACOGENETICS, 1996, 6 (03): : 243 - 250
  • [27] Lachman HM, 1998, AM J PSYCHIAT, V155, P835
  • [28] Lachman HM, 1997, AM J MED GENET, V74, P121, DOI 10.1002/(SICI)1096-8628(19970418)74:2<121::AID-AJMG2>3.0.CO
  • [29] 2-X
  • [30] GENETIC DISSECTION OF COMPLEX TRAITS - GUIDELINES FOR INTERPRETING AND REPORTING LINKAGE RESULTS
    LANDER, E
    KRUGLYAK, L
    [J]. NATURE GENETICS, 1995, 11 (03) : 241 - 247